BioCryst Pharmaceuticals Inc (BCRX)
4.45
-0.03
(-0.67%)
USD |
NASDAQ |
May 03, 16:00
4.43
-0.02
(-0.45%)
Pre-Market: 20:00
BioCryst Pharmaceuticals 1 Year Total Returns (Daily): -46.32% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -46.32% |
May 02, 2024 | -39.21% |
May 01, 2024 | -39.15% |
April 30, 2024 | -45.73% |
April 29, 2024 | -43.89% |
April 26, 2024 | -45.41% |
April 25, 2024 | -44.46% |
April 24, 2024 | -44.68% |
April 23, 2024 | -41.76% |
April 22, 2024 | -41.36% |
April 19, 2024 | -40.85% |
April 18, 2024 | -40.00% |
April 17, 2024 | -43.25% |
April 16, 2024 | -42.87% |
April 15, 2024 | -42.13% |
April 12, 2024 | -42.81% |
April 11, 2024 | -40.00% |
April 10, 2024 | -42.84% |
April 09, 2024 | -44.70% |
April 08, 2024 | -46.89% |
April 05, 2024 | -46.07% |
April 04, 2024 | -44.58% |
April 03, 2024 | -43.49% |
April 02, 2024 | -43.76% |
April 01, 2024 | -39.45% |
Date | Value |
---|---|
March 28, 2024 | -40.86% |
March 27, 2024 | -39.13% |
March 26, 2024 | -41.06% |
March 25, 2024 | -42.24% |
March 22, 2024 | -36.90% |
March 21, 2024 | -32.80% |
March 20, 2024 | -31.71% |
March 19, 2024 | -33.83% |
March 18, 2024 | -37.41% |
March 15, 2024 | -40.26% |
March 14, 2024 | -41.23% |
March 13, 2024 | -38.15% |
March 12, 2024 | -38.00% |
March 11, 2024 | -35.83% |
March 08, 2024 | -36.57% |
March 07, 2024 | -40.12% |
March 06, 2024 | -41.06% |
March 05, 2024 | -38.45% |
March 04, 2024 | -37.32% |
March 01, 2024 | -36.35% |
February 29, 2024 | -36.38% |
February 28, 2024 | -35.48% |
February 27, 2024 | -34.99% |
February 26, 2024 | -36.37% |
February 23, 2024 | -39.51% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.30%
Minimum
Mar 18 2020
693.1%
Maximum
Mar 18 2021
37.07%
Average
-19.03%
Median
Jun 08 2023
1 Year Total Returns (Daily) Benchmarks
Integra Lifesciences Holdings Corp | -43.74% |
Krystal Biotech Inc | 91.99% |
AIM ImmunoTech Inc | -15.65% |
Protalix BioTherapeutics Inc | -63.81% |
Armata Pharmaceuticals Inc | 61.69% |